0001654954-20-000308.txt : 20200110
0001654954-20-000308.hdr.sgml : 20200110
20200110213402
ACCESSION NUMBER: 0001654954-20-000308
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200108
FILED AS OF DATE: 20200110
DATE AS OF CHANGE: 20200110
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pay Paul William
CENTRAL INDEX KEY: 0001778480
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37619
FILM NUMBER: 20522407
MAIL ADDRESS:
STREET 1: C/O EDESA BIOTECH INC.
STREET 2: 100 SPY COURT
CITY: MARKHAM
STATE: A6
ZIP: L3R 5H6
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Edesa Biotech, Inc.
CENTRAL INDEX KEY: 0001540159
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 100 SPY COURT
CITY: MARKHAM
STATE: A6
ZIP: L3R 5H6
BUSINESS PHONE: (905) 475-1234
MAIL ADDRESS:
STREET 1: 100 SPY COURT
CITY: MARKHAM
STATE: A6
ZIP: L3R 5H6
FORMER COMPANY:
FORMER CONFORMED NAME: Stellar Biotechnologies, Inc.
DATE OF NAME CHANGE: 20120120
4
1
section16.xml
PRIMARY DOCUMENT
X0306
4
2020-01-08
0001540159
Edesa Biotech, Inc.
EDSA
0001778480
Pay Paul William
C/O EDESA BIOTECH INC.
100 SPY COURT
MARKHAM
A6
L3R 5H6
ONTARIO, CANADA
true
Common Shares
2020-01-08
4
A
false
2436
4.11
A
2436
D
Common Share Warrants (Right to Buy)
4.80
2020-01-08
4
A
false
1827
A
2020-07-08
2023-07-08
Common Shares
1827
1827
D
Common Share Warrants (Right to Buy)
4.00
2020-01-08
4
A
false
1218
A
2020-07-08
2020-11-08
Common Shares
1218
1218
D
The reported securities are included within 2,436 Common Shares purchased by the reporting person for $4.11 per Common Share. Each Common Share includes the purchase of Class A Warrants to purchase 0.75 of a Common Share, and Class B Warrants to purchase 0.50 of a Common Share.
Consists of Class A Warrants to purchase Common Shares. The Class A Warrants are exercisable beginning on July 8, 2020 and expire on July 8, 2023.
Consists of Class B Warrants to purchase Common Shares. The Class B Warrants are exercisable beginning on July 8, 2020 and expire on November 8, 2020.
/s/ Paul William Pay
2020-01-10